Cannonau Financial Statements From 2010 to 2025

CNNC Stock  USD 0.0003  0.00  0.00%   
Cannonau Corp's financial statements offer valuable quarterly and annual insights to potential investors, highlighting the company's current and historical financial position, overall management performance, and changes in financial standing over time. Key fundamentals influencing Cannonau Corp's valuation are provided below:
Cannonau Corp does not presently have any fundamental signals for analysis.
Check Cannonau Corp financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Cannonau Corp's main balance sheet or income statement drivers, such as , as well as many indicators such as . Cannonau financial statements analysis is a perfect complement when working with Cannonau Corp Valuation or Volatility modules.
  
This module can also supplement various Cannonau Corp Technical models . Check out the analysis of Cannonau Corp Correlation against competitors.

Cannonau Corp Company Shares Outstanding Analysis

Cannonau Corp's Outstanding Shares are shares of common stock of a public company that were purchased by investors after they were authorized and issued by the company to the public. Outstanding Shares are typically reported on fully diluted basis, including exotic instruments such as options, or convertibles bonds.

Shares Outstanding

 = 

Public Shares

-

Repurchased

More About Shares Outstanding | All Equity Analysis

Current Cannonau Corp Shares Outstanding

    
  253.66 M  
Most of Cannonau Corp's fundamental indicators, such as Shares Outstanding, are part of a valuation analysis module that helps investors searching for stocks that are currently trading at higher or lower prices than their real value. If the real value is higher than the market price, Cannonau Corp is considered to be undervalued, and we provide a buy recommendation. Otherwise, we render a sell signal.
Outstanding shares that are stated on company Balance Sheet are used when calculating many important valuation and performance indicators including Return on Equity, Market Cap, EPS and many others.
Competition

Based on the latest financial disclosure, Cannonau Corp has 253.66 M of shares currently outstending. This is 40.51% higher than that of the Healthcare sector and significantly higher than that of the Drug Manufacturers—Specialty & Generic industry. The shares outstanding for all United States stocks is 55.64% higher than that of the company.

Cannonau Corp Fundamental Drivers Relationships

Comparative valuation techniques use various fundamental indicators to help in determining Cannonau Corp's current stock value. Our valuation model uses many indicators to compare Cannonau Corp value to that of its competitors to determine the firm's financial worth. You can analyze the relationship between different fundamental ratios across Cannonau Corp competition to find correlations between indicators driving Cannonau Corp's intrinsic value. More Info.
Cannonau Corp is rated below average in return on asset category among its peers. It is rated fifth in operating margin category among its peers . Comparative valuation analysis is a catch-all model that can be used if you cannot value Cannonau Corp by discounting back its dividends or cash flows. This model doesn't attempt to find an intrinsic value for Cannonau Corp's Pink Sheet. Still, instead, it compares the stock's price multiples to a benchmark or nearest competition to determine if the stock is relatively undervalued or overvalued.

About Cannonau Corp Financial Statements

Cannonau Corp stakeholders use historical fundamental indicators, such as Cannonau Corp's revenue or net income, to determine how well the company is positioned to perform in the future. Although Cannonau Corp investors may analyze each financial statement separately, they are all interrelated. For example, changes in Cannonau Corp's assets and liabilities are reflected in the revenues and expenses on Cannonau Corp's income statement, which ultimately affect the company's gains or losses. Understanding these patterns can help in making the right long-term investment decisions in Cannonau Corp. Please read more on our technical analysis and fundamental analysis pages.
Cannonau Corp. engages in developing cannabidiol based products. Cannonau Corp. was incorporated in 2007 and is based in Skaneateles, New York. CANNONAU CORP operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange. It employs 4 people.

Also Currently Popular

Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.

Other Information on Investing in Cannonau Pink Sheet

Cannonau Corp financial ratios help investors to determine whether Cannonau Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Cannonau with respect to the benefits of owning Cannonau Corp security.